Rank |
Title |
Year |
PubWeight™‹?› |
51
|
Epithelial barriers in homeostasis and disease.
|
2010
|
2.28
|
52
|
Proteases in parasitic diseases.
|
2006
|
2.26
|
53
|
Glioblastoma: from molecular pathology to targeted treatment.
|
2013
|
2.24
|
54
|
The pathology of chronic obstructive pulmonary disease.
|
2009
|
2.23
|
55
|
Psoriasis.
|
2011
|
2.21
|
56
|
p63 in epithelial survival, germ cell surveillance, and neoplasia.
|
2010
|
2.21
|
57
|
Autophagy as a stress-response and quality-control mechanism: implications for cell injury and human disease.
|
2012
|
2.20
|
58
|
Human microbiome in health and disease.
|
2011
|
2.18
|
59
|
Endometrial carcinoma.
|
2007
|
2.13
|
60
|
Endocrine functions of adipose tissue.
|
2007
|
2.13
|
61
|
Host responses in tissue repair and fibrosis.
|
2012
|
2.10
|
62
|
Disorders of bone remodeling.
|
2011
|
2.05
|
63
|
Lung cancer preneoplasia.
|
2006
|
2.04
|
64
|
The brainstem and serotonin in the sudden infant death syndrome.
|
2009
|
2.03
|
65
|
Caveolin-1 and cancer metabolism in the tumor microenvironment: markers, models, and mechanisms.
|
2011
|
2.03
|
66
|
Mutational heterogeneity in human cancers: origin and consequences.
|
2010
|
2.02
|
67
|
Pathogenesis of antineutrophil cytoplasmic autoantibody-associated small-vessel vasculitis.
|
2013
|
2.02
|
68
|
The multifaceted functions of neutrophils.
|
2013
|
1.97
|
69
|
The pathogenesis of mixed-lineage leukemia.
|
2011
|
1.95
|
70
|
Tuberculosis pathogenesis and immunity.
|
2011
|
1.92
|
71
|
Pathogenesis of myeloma.
|
2011
|
1.91
|
72
|
EGFR mutations and lung cancer.
|
2011
|
1.89
|
73
|
Digital imaging in pathology: whole-slide imaging and beyond.
|
2012
|
1.89
|
74
|
IgG4-related disease.
|
2013
|
1.89
|
75
|
Progressive multifocal leukoencephalopathy: why gray and white matter.
|
2012
|
1.88
|
76
|
Molecular pathology of head and neck cancer: implications for diagnosis, prognosis, and treatment.
|
2009
|
1.88
|
77
|
Molecular biology and pathogenesis of viral myocarditis.
|
2008
|
1.87
|
78
|
Cell-based therapy for myocardial ischemia and infarction: pathophysiological mechanisms.
|
2007
|
1.86
|
79
|
Metastatic cancer cell.
|
2008
|
1.85
|
80
|
Malaria: mechanisms of erythrocytic infection and pathological correlates of severe disease.
|
2007
|
1.83
|
81
|
The Th17 pathway and inflammatory diseases of the intestines, lungs, and skin.
|
2012
|
1.80
|
82
|
Molecular pathogenesis and diagnostics of bladder cancer.
|
2009
|
1.79
|
83
|
Linking the cellular functions of BRCA genes to cancer pathogenesis and treatment.
|
2009
|
1.77
|
84
|
Molecular pathogenesis of Ewing sarcoma: new therapeutic and transcriptional targets.
|
2011
|
1.70
|
85
|
Pathogenesis of thrombotic microangiopathies.
|
2008
|
1.69
|
86
|
Serrated polyps and colorectal cancer: new pathway to malignancy.
|
2009
|
1.69
|
87
|
Drosophila models of neurodegenerative diseases.
|
2009
|
1.67
|
88
|
Pathogenesis of the viral hemorrhagic fevers.
|
2012
|
1.63
|
89
|
ATM and the molecular pathogenesis of ataxia telangiectasia.
|
2011
|
1.61
|
90
|
Mouse models of cancer.
|
2011
|
1.59
|
91
|
Regulation of hepcidin and iron-overload disease.
|
2009
|
1.58
|
92
|
Molecular pathogenesis of necrotizing fasciitis.
|
2010
|
1.56
|
93
|
Pathobiology of neutrophil transepithelial migration: implications in mediating epithelial injury.
|
2007
|
1.55
|
94
|
Modeling morphogenesis and oncogenesis in three-dimensional breast epithelial cultures.
|
2008
|
1.55
|
95
|
The pathogenesis of systemic sclerosis.
|
2011
|
1.54
|
96
|
Pathology of demyelinating diseases.
|
2012
|
1.52
|
97
|
Pathogenesis of idiopathic pulmonary fibrosis.
|
2013
|
1.51
|
98
|
Mechanisms of endothelial dysfunction, injury, and death.
|
2009
|
1.48
|
99
|
Calcium in cell injury and death.
|
2006
|
1.48
|
100
|
Gene expression profiling of breast cancer.
|
2008
|
1.47
|